| Product Code: ETC10327669 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Latvia saw a significant increase in spine biologics import shipments, with top exporting countries including Metropolitan France, Germany, Lithuania, Poland, and the USA. The market remained highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). Despite a strong compound annual growth rate (CAGR) of 43.42% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 at -57.01%. This fluctuation may reflect changing market dynamics and potential shifts in demand for spine biologics in Latvia.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Latvia Spine Biologics Market Overview | 
| 3.1 Latvia Country Macro Economic Indicators | 
| 3.2 Latvia Spine Biologics Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Latvia Spine Biologics Market - Industry Life Cycle | 
| 3.4 Latvia Spine Biologics Market - Porter's Five Forces | 
| 3.5 Latvia Spine Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F | 
| 3.6 Latvia Spine Biologics Market Revenues & Volume Share, By End User, 2021 & 2031F | 
| 3.7 Latvia Spine Biologics Market Revenues & Volume Share, By Application Type, 2021 & 2031F | 
| 3.8 Latvia Spine Biologics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F | 
| 3.9 Latvia Spine Biologics Market Revenues & Volume Share, By Technology, 2021 & 2031F | 
| 4 Latvia Spine Biologics Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.3 Market Restraints | 
| 5 Latvia Spine Biologics Market Trends | 
| 6 Latvia Spine Biologics Market, By Types | 
| 6.1 Latvia Spine Biologics Market, By Product Type | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Latvia Spine Biologics Market Revenues & Volume, By Product Type, 2021 - 2031F | 
| 6.1.3 Latvia Spine Biologics Market Revenues & Volume, By Bone Grafts, 2021 - 2031F | 
| 6.1.4 Latvia Spine Biologics Market Revenues & Volume, By Spinal Implants, 2021 - 2031F | 
| 6.1.5 Latvia Spine Biologics Market Revenues & Volume, By Bone Morphogenetic Proteins, 2021 - 2031F | 
| 6.2 Latvia Spine Biologics Market, By End User | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Latvia Spine Biologics Market Revenues & Volume, By Hospitals, 2021 - 2031F | 
| 6.2.3 Latvia Spine Biologics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F | 
| 6.2.4 Latvia Spine Biologics Market Revenues & Volume, By Spine Clinics, 2021 - 2031F | 
| 6.3 Latvia Spine Biologics Market, By Application Type | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Latvia Spine Biologics Market Revenues & Volume, By Spinal Fusion, 2021 - 2031F | 
| 6.3.3 Latvia Spine Biologics Market Revenues & Volume, By Degenerative Disc Disease, 2021 - 2031F | 
| 6.3.4 Latvia Spine Biologics Market Revenues & Volume, By Spinal Deformities, 2021 - 2031F | 
| 6.4 Latvia Spine Biologics Market, By Treatment Type | 
| 6.4.1 Overview and Analysis | 
| 6.4.2 Latvia Spine Biologics Market Revenues & Volume, By Stem Cells, 2021 - 2031F | 
| 6.4.3 Latvia Spine Biologics Market Revenues & Volume, By Allograft, 2021 - 2031F | 
| 6.4.4 Latvia Spine Biologics Market Revenues & Volume, By Gene Therapy, 2021 - 2031F | 
| 6.5 Latvia Spine Biologics Market, By Technology | 
| 6.5.1 Overview and Analysis | 
| 6.5.2 Latvia Spine Biologics Market Revenues & Volume, By Osteobiologics, 2021 - 2031F | 
| 6.5.3 Latvia Spine Biologics Market Revenues & Volume, By Biologic Grafts, 2021 - 2031F | 
| 6.5.4 Latvia Spine Biologics Market Revenues & Volume, By Carrier Materials, 2021 - 2031F | 
| 7 Latvia Spine Biologics Market Import-Export Trade Statistics | 
| 7.1 Latvia Spine Biologics Market Export to Major Countries | 
| 7.2 Latvia Spine Biologics Market Imports from Major Countries | 
| 8 Latvia Spine Biologics Market Key Performance Indicators | 
| 9 Latvia Spine Biologics Market - Opportunity Assessment | 
| 9.1 Latvia Spine Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F | 
| 9.2 Latvia Spine Biologics Market Opportunity Assessment, By End User, 2021 & 2031F | 
| 9.3 Latvia Spine Biologics Market Opportunity Assessment, By Application Type, 2021 & 2031F | 
| 9.4 Latvia Spine Biologics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F | 
| 9.5 Latvia Spine Biologics Market Opportunity Assessment, By Technology, 2021 & 2031F | 
| 10 Latvia Spine Biologics Market - Competitive Landscape | 
| 10.1 Latvia Spine Biologics Market Revenue Share, By Companies, 2024 | 
| 10.2 Latvia Spine Biologics Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |